PDS Biotechnology SEC filings: 8-K
Filter: All · 8-K · 10-Q · 10-K · Form 4
Other events · Financial statements and exhibits
AI summary, unreviewedPDS Biotechnology posts updated corporate presentation (Exhibit 99.1) with no new financial results, highlighting PDS0301 data and five readouts through Q2 2028
Departure/appointment of directors or officers · Other events · Financial statements and exhibits
AI summary, unreviewedPDS Biotechnology Corp board overhaul: four directors resign, three pharma executives appointed, no financial results disclosed
Other events · Financial statements and exhibits
Other events · Financial statements and exhibits
Other events · Financial statements and exhibits
Termination of a material definitive agreement · Departure/appointment of directors or officers · Regulation FD disclosure · Other events · Financial statements and exhibits
Entry into a material definitive agreement · Unregistered sales of equity securities · Regulation FD disclosure · Financial statements and exhibits
Entry into a material definitive agreement · Creation of a direct financial obligation · Financial statements and exhibits
Costs of exit or disposal activities · Departure/appointment of directors or officers
Departure/appointment of directors or officers
Amendments to articles or bylaws; fiscal year change · Submission of matters to a vote of security holders · Financial statements and exhibits
Results of operations and financial condition · Financial statements and exhibits
Regulation FD disclosure · Financial statements and exhibits
Delisting notice / failure to meet listing standard